PRTG
ABBV icon

Post Resch Tallon Group’s AbbVie ABBV Stock Holding History

Post Resch Tallon Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$432K Sell
1,651
-13
-0.8% -$3.33K 0.3% 66
2026
Q2 		$419K Hold
1,664
– – 0.29% 62
2026
Q1 		$366K Hold
1,664
– – 0.3% 64
2025
Q4 		$380K Sell
1,664
-57
-3% -$13K 0.32% 56
2025
Q3 		$398K Hold
1,721
– – 0.35% 53
2025
Q2 		$319K Hold
1,721
– – 0.31% 59
2025
Q1 		$356K Hold
1,721
– – 0.36% 53
2024
Q4 		$309K Buy
+1,721
New +$316K 0.3% 59

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Post Resch Tallon Group's ABBV Position: Q3 2026 in Review

Post Resch Tallon Group reduced its AbbVie (ABBV) stake by 0.78% in Q3 2026, selling an estimated $3.33K and leaving 1,651 shares worth $432K. The position accounts for 0.3% of the portfolio, ranked #66.

Post Resch Tallon Group first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Post Resch Tallon Group held 1,651 shares of AbbVie worth $432K as of Q3 2026.
  • Post Resch Tallon Group sold 13 AbbVie shares in Q3 2026, an estimated $3.33K.
  • AbbVie made up 0.3% of Post Resch Tallon Group's portfolio in Q3 2026, its #66 holding.
  • Post Resch Tallon Group first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Post Resch Tallon Group's 13F filing for Q3 2026, filed 9 Oct 2026.